Investigator Initiated Phase 1 Study of TBI-1201

Condition:   Solid Tumors
Interventions:   Drug: TBI-1201;   Drug: Cyclophosphamide;   Drug: Fludarabine
Sponsors:   Mie University;   Takara Bio Inc.;   Shionogi;   Fiverings Co., Ltd.;   Statcom Co. Ltd.
Recruiting - verified March 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1UQnfcD
via IFTTT